Polymorphism in Vitamin D-Binding Protein as a Genetic Risk Factor in the Pathogenesis of Endometriosis

Klaus Faserl, Georg Golderer, Leopold Kremser, Herbert Lindner, Bettina Sarg, L. Wildt, Ludwig Wildt, Beata Seeber
The Journal of clinical endocrinology and metabolism · 2010 · vol. 96(1) , pp. E233–E241 · doi:10.1210/jc.2010-1532 · PMID:20980430 · W2159152105
article OA: bronze CC0 ⤵ 40 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study found higher levels of the vitamin D-binding protein GC*2 allele product in women with endometriosis, potentially impairing macrophage function and contributing to disease pathogenesis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

CONTEXT: Previous studies have implicated a deficiency in the inflammatory response in women who develop endometriosis. The specific immunological deficits have not been completely elucidated. OBJECTIVE: Our objective was to identify differences in protein expression in serum that might shed light on the pathophysiology of endometriosis. DESIGN AND SETTING: This cross-sectional study of women undergoing laparoscopy between 2003 and 2005 took place at a university medical center. PATIENTS: Patients included consenting women age 18-49 yr undergoing surgery for pain and/or infertility or elective tubal ligation. Women with acute or chronic medical conditions were excluded. INTERVENTION: Blood was collected preoperatively. MAIN OUTCOME MEASURE: Proteomic analysis of serum was done using two-dimensional difference gel electrophoresis. RESULTS: We found 25 protein spots with a significant difference in abundance between women with endometriosis and controls, including acute-phase proteins and complement components. The abundance of vitamin D-binding protein was higher in all endometriosis pools by a factor of approximately 3 compared with the control pool (P < 0.02). Analysis of specific allele products using nano-scale liquid chromatography-electrospray ionization-mass spectrometry indicated that it was the GC*2 allele product that was in greater concentration in serum pools, as well as in single validation samples, in women with endometriosis (P = 0.006). In contrast to the GC*1 allele product, which is readily converted to a potent macrophage factor (Gc protein-derived macrophage-activating factor), the GC*2 allele product undergoes practically no such conversion. CONCLUSIONS: We speculate that the inability to sufficiently activate macrophages' phagocytotic function in those carrying the GC*2 polymorphism (more prevalent in endometriosis) may allow endometriotic tissues to implant in the peritoneal cavity. Future studies evaluating specific vitamin D-binding protein polymorphisms as a risk factor for endometriosis in larger populations of women are warranted.

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosisinfertility

MeSH descriptors

Endometriosis Polymorphism, Genetic Vitamin D-Binding Protein Alleles Chromatography, Liquid Cross-Sectional Studies Electrophoresis, Gel, Two-Dimensional Endometriosis Endometriosis Female Humans Mass Spectrometry Risk Factors Vitamin D-Binding Protein Vitamin D-Binding Protein

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (46)

Cited by (40)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:17:00.782903+00:00
License: CC0 · commercial use OK